Barriers to the quality delivery of seasonal malaria chemoprevention in Chad and Burkina Faso: a qualitative exploration of caregivers and community distributors' perspectives.

Autor: Lasmi K; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden. kevin.lasmi@gmail.com., Elimian K; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden., Donovan L; Malaria Consortium, London, UK., Tounaikok N; Malaria Consortium, Chad Country Office, N'Djamena, Chad., Traoré A; Malaria Consortium, Burkina Faso Country Office, Ouagadougou, Burkina Faso., Gils T; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.; Global Health Institute, University of Antwerp, Wilrijk, Belgium., Rassi C; Malaria Consortium, London, UK., Marasciulo M; Malaria Consortium US, Raleigh, NC, USA., Richardson S; Vanke School of Public Health, Tsinghua University, Beijing, China., Tougri G; Programme national de lutte contre le paludisme, Ouagadougou, Burkina Faso., Diar MSI; Programme national de lutte contre le paludisme, N'Djamena, Chad., Baker K; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.; Malaria Consortium, London, UK.
Jazyk: angličtina
Zdroj: Malaria journal [Malar J] 2024 Jul 19; Vol. 23 (1), pp. 216. Date of Electronic Publication: 2024 Jul 19.
DOI: 10.1186/s12936-024-05034-6
Abstrakt: Background: Recommended since 2012 by the World Health Organization (WHO), seasonal malaria chemoprevention (SMC) is a community-based intervention to prevent malaria in children in African regions where malaria transmission follows a seasonal pattern. Following the publication of consolidated WHO guidelines for malaria, SMC is expected to reach more children in new geographies in future years. Though SMC has been shown to reduce malaria-related morbidity and mortality, there is potential for quality improvement of the intervention implementation. Assisted by ten quality standards from a framework developed by Malaria Consortium, this paper aims to better understand the quality of SMC implementation and identify potential barriers to quality delivery of SMC.
Methods: A qualitative thematic analysis on data collected after the annual SMC rounds implemented in Burkina Faso and Chad in 2019 was conducted. Sixteen focus group discussions conducted with caregivers and community distributors were analysed. Three selected quality standards for SMC delivery; planning and enumeration; community engagement; and administration of SMC medicines provided overarching quality themes under which subthemes were identified.
Results: Eight subthemes relating to the three quality standards were identified. Although SMC was well accepted by communities in both settings, common barriers to the quality delivery of SMC were identified including difficulty ensuring adherence to the SMC administration protocol; difficulties reaching mobile populations; concerns around adverse drug reactions; rumours, and concerns about SMC safety; and community distributors' working conditions. Context-specific barriers included: the suboptimal timeliness of the SMC round in Burkina Faso, and the lack of involvement of female caregivers in mobilization activities in Chad.
Conclusion: In the context of increased adoption of SMC, this paper provides relevant insights and recommendations for the improved implementation of SMC programmes. These include the integration of strategies addressing communities' concerns around adverse drug reactions, gender-specific mobilization strategies, and attention to community distributors' working conditions. It also highlights the importance and utility of further, robust research on the quality of SMC delivery.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje